Re: AMERICAN OPTICAL CORPORATION & AO INC.
And: ALLERGAN PHARMACEUTICALS PTY. LIMITED; AMERICAN OPTICAL CORPORATION;
ALCON LABORATORIES (AUSTRALIA) PTY. LIMITED; AO INC.
No. G.406 of 1984
Jurisdiction
4 IPR 1
COURT
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES REGISTRY
GENERAL DIVISION
Beaumont J.
CATCHWORDS
Jurisdiction - joinder of action under Trade Practices Act 1974 with action under Patents Act 1952 - s.32 Federal Court of Australia Act 1976 - whether associated matter - Order 6 rule 6 Federal Court Rules - discretion whether separate trials should be ordered.
Philip Morris Inc. v. Adam P. Brown Male Fashions Pty Ltd (1981) 148 CLR - con
Superstar Australia Pty Ltd v. Coonan & Denley Pty Ltd (1981) 57 FLR 110 - con
Rolls Royce Motors Ltd v. D.I.A. (Engineering) Pty Ltd (1981) 50 FLR 340 - con
Stack v. Coast Securities (No. 9) Pty Ltd (1983) 49 ALT 193 - con
HEARING
SYDNEY
#DATE 15:3:1985
ORDER
1. The respondent's application be dismissed.
2. Costs of the application be applicant's costs in proceedings.
JUDGE1
By its notice of motion, the respondent moves for orders, inter alia, striking out paras. 5, 6, 22, 23, 24, 25, 26 and 27 of the Statement of Claim in this matter.
By their application and statement of claim, the applicants make a number of claims for relief. In the first place, they seek relief under ss.80 and 82 and, possibly, s.87 of the Trade Practices Act, 1974 ("the Trade Practices Act") by reason of alleged contraventions by the respondent of s.52, 53(a), 53(c), 53(d), 53(e) and 55 of the Trade Practices Act. These contraventions are charged in paras. 4 to 21 of the Statement of Claim. In those paragraphs, the applicants allege that the second applicant is, and has been since 6 August 1982, registered under the Patents Act, 1952 ("the Patents Act") as the proprietor of the Australian Letters Patent No. 465, 844 ("the Patent") for an invention entitled "Method for removing hydrogen peroxide from soft contact lenses."; that the Patent was sealed on 4 February 1976 (para.5); and that the first applicant is the exclusive licensee of the second applicant (para.6). The applicants claim that since February 1982, the first applicant has manufactured products for the disinfecting and cleaning of soft contact lenses pursuant to the Patent under the names "Lensept" and "Lensrins NT", which comprise part of the "Septicon System" for the disinfecting and cleaning of soft contact lenses (para 7).
The applicants then allege that the respondent markets and sells in Australia a hydrogen peroxide system employing a hydrogen peroxide decomposition catalyst, for the disinfecting and cleaning of soft contact lenses under the name "Oxysept": the applicants say that in the promotion, marketing and sale of the said "Oxysept" products the respondent has adopted a get-up which is the same as, or alternatively deceptively similar to or alternatively substantially identical with the distinctive get-up of the second applicant (para.10). The applicants charge that the respondent has induced a belief that the "Oxysept"…
Keep reading for free
Create a free CaseChat account to read American Optical Corporation v Allergan Pharmaceuticals Pty... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1985] FCA 84
- Decision Date
CaseChat Overview and Summary
The court examined the nature of the claims and the common factual matrix they shared. It considered the legislative intent behind the joinder provisions and whether the actions indeed constituted associated matters. The court noted the discretion available to it under Order 6 rule 6 of the Federal Court Rules to decide whether separate trials should be ordered. It assessed whether a single trial would be more convenient, efficient, or just, and whether there was any risk of unfairness to either party if the actions were tried together.
After evaluating the arguments and the relevant legal framework, the court concluded that the actions did not meet the criteria for being associated matters under the Act. The court found that the actions did not share a sufficient common subject matter, and there was no basis for concluding that they constituted associated matters. Consequently, the court dismissed the application for joinder and ruled that the costs of the application should be borne by the applicant.
Orders
Orders of the court
1. The respondent's application be dismissed.
2. Costs of the application be applicant's costs in proceedings.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi